Vaccinex files to sell 433.5K common shares for holders
Slightly above 67% of Vaccinex's investor base is looking to short. The analysis of overall sentiment of trading Vaccinex stock suggests that many investors are alarmed at this time. Vaccinex's investing sentiment can be driven by a variety of factors including economic data, Vaccinex's earnings reports, geopolitical events, and overall market trends.
Vaccinex |
Vaccinex files prospectus for the proposed resale of 433.5K common shares by selling stockholders.
Read at seekingalpha.com
 |
Vaccinex Fundamental Analysis
We analyze Vaccinex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaccinex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaccinex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Vaccinex is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Vaccinex Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaccinex stock to make a market-neutral strategy. Peer analysis of Vaccinex could also be used in its relative valuation, which is a method of valuing Vaccinex by comparing valuation metrics with similar companies.
Peers
Vaccinex Related Equities
| SABS | SAB Biotherapeutics | 13.14 | ||||
| SRZN | Surrozen | 9.44 | ||||
| FBRX | Forte Biosciences | 7.62 | ||||
| GOVX | GeoVax Labs | 1.17 | ||||
| RNXT | RenovoRx | 0.97 | ||||
| ELDN | Eledon Pharmaceuticals | 0.89 | ||||
| SLRX | Salarius Pharmaceuticals | 2.41 | ||||
| MNPR | Monopar Therapeutics | 3.54 | ||||
| ERAS | Erasca | 3.68 | ||||
| TARA | Protara Therapeutics | 4.81 | ||||
| ANEB | Anebulo Pharmaceuticals | 7.64 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Vaccinex Stock
If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |